Radioimmunochemical Analysis of Human Erythrocyte Adenosine Deaminase

  • Peter E. Daddona
  • Michael A. Frohman
  • William N. Kelley
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 122B)


Adenosine deaminase (adenosine aminohydrolase, EC catalyzes the irreversible hydrolytic deamination of adenosine to produce inosine and ammonia. Markedly reduced or absent adenosine deaminase activity in man is associated with an autosomal recessive form of severe combined immunodeficiency disease and the relationship appears to be causal.1,2,3,4 Affected patients present a defect of both cellular and humoral immunity characterized clinically by severe recurrent infections with a uniformly fatal outcome if untreated.


Adenosine Deaminase Severe Combine Immunodeficiency Severe Combine Immunodeficiency Disease Autosomal Recessive Form Amniotic Fluid Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    E. R. Giblett, J. E. Anderson, F. Cohen, B. Pollara and H. J. Meuwissen, Adenosine deaminase deficiency in two patients with severely impaired cellular immunity Lancet 2:1067–1069 (1972).PubMedCrossRefGoogle Scholar
  2. 2.
    J. Dissing and B. Knudsen, Adenosine deaminase deficiency and combined immunodeficiency syndrome Lancet 2: 1316 (1972).PubMedCrossRefGoogle Scholar
  3. 3.
    R. Parkman, E. W. Gelfand, F. S. Rosen, A. Sanderson and R. Hirschhorn, Severe combined immunodeficiency and adenosine deaminase deficiency New Eng. J. Med. 292:714–719 (1975).PubMedCrossRefGoogle Scholar
  4. 4.
    H. J. Meuwissen, B. Pollara and R. J. Pickering, Combined immunodeficiency disease associated with adenosine deaminase deficiency J. Pediatrics 86:169–181 (1975).CrossRefGoogle Scholar
  5. 5.
    S. H. Chen, C. R. Scott and K. R. Swedberg, Adenosine deaminase deficiency: expression of the enzyme in cultured skin fibroblasts and amniotic fluid cells, Am. J. Hum. Genet. 27:46–53 (1975).PubMedGoogle Scholar
  6. 6.
    R. Hirschhorn, N. Beratis and F. S. Rosen, Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme Proc. Natl. Acad. Sci. 73:213–217 (1976).PubMedCrossRefGoogle Scholar
  7. 7.
    R. Hirschhorn, F. Martiniuk and F. S. Rosen, Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency Clin. Immunol. and Immunopath. 9:287–292 (1978).CrossRefGoogle Scholar
  8. 8.
    D. A. Carson, R. Goldblum and J. E. Seegmiller, Quantitative immunoassay of adenosine deaminase in combined immunodeficiency disease J. Immunol. 118:270–273 (1977).PubMedGoogle Scholar
  9. 9.
    P. E. Daddona and W. N. Kelley, Human adenosine deaminase: purification and subunit structure J. Biol. Chem. 252:110–115 (1977).PubMedGoogle Scholar
  10. 10.
    W. P. Schrader, A. R. Stacy and B. Pollara, Purification of human erythrocyte adenosine deaminase by affinity column chromatography J. Biol. Chem. 251:4026–4032 (1976).PubMedGoogle Scholar
  11. 11.
    D. Rodbard, W. Bridson and P. L. Payford, Rapid calculation of radioimmunoassay results J. Lab. and Clin. Med. 74:770–781 (1969).Google Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Peter E. Daddona
    • 1
  • Michael A. Frohman
    • 1
  • William N. Kelley
    • 1
  1. 1.Departments of Internal Medicine and Biological Chemistry, Human Purine Research CenterUniversity of Michigan Medical SchoolAnn ArborUSA

Personalised recommendations